인쇄하기
취소
|
Both pharmaceutical companies and biopharmaceutical ventures are actively researching and developing new drugs having potentials to be expanded into the global market. In particular, technological exports are expected this year.
According to the Hana Financial Investment’s report on the 15th, the Hanmi Pharm’s adult dwarfism treatment, HM10560A, has been analyzed to have a high chance to be ex...